On Fri, 26 Nov 2010 20:44:25 -0500, wrote:

On Fri, 26 Nov 2010 14:51:58 -0800, wrote:

On Thu, 25 Nov 2010 22:09:26 -0500, wrote:

On Thu, 25 Nov 2010 18:44:39 -0800 (PST), Frogwatch
wrote:

Maybe it cost that much to produce. R&D aint cheap

That is the problem with all of the "orphan" diseases. If you spend
$50 million developing a drug that only goes to 10 thousand paying
patients, it is going to be expensive.

So, therefore, it should not be up to for-profit companies. It should
be the responsibility of the state to "promote the general welfare" of
its citizens.

The reality is the same, whether it is the taxpayer or the people who
buy drug insurance or just the patient himself. It will still be
expensive per patient and there is always a cost benefit analysis.

If you are honestly suggesting the government should be developing
these drugs, I would ask, which breakthrough drug has the government
ever developed?
Just look at the human genome project. The government spent a lot of
money and got nowhere for over a decade. A private company tackled the
project and broke the code in months.

The cost will not be the same, since the gov't wouldn't be spending a
large percentage of money on adverts to "promote" the drug. In
addition, the overhead would be lower, and most importantly, most of
the orphan disease drugs would not be even developed by the for-profit
drug companies.

http://www.sciencedaily.com/releases...0105140107.htm

I'm not suggesting the gov't do the R&D. Rather the development should
be done in a similar way flu vaccines are created.

Somewhat dated, but here's a timeline...

http://www.influenza.com/images/timeline.gif